LP
Lotus Pharmaceuticals, Inc. Stock: price and insider trades · United States
Lotus Pharmaceuticals, Inc.: what insiders have been doing
Lotus Pharmaceuticals, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Lotus Pharmaceuticals, Inc. has published a filing in the past twelve months. The most recent one dates from 26 May 2011.
Our records for Lotus Pharmaceuticals, Inc. go back to 2007, with no purchases and 3 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€296,665
3 ops. · all time
Financial data
as of FY 2011FY ended September 2011 · cache
Last declaration on 26 May 2011
Declarations8 total
- 498,646 shares0Common StockSEC:0001161697-11-000486:0
- 5,000 shares@ US$0.95Common StockSEC:0001493625-10-000001:0
- 30,000 shares@ US$1.00Common StockSEC:0001161697-08-000008:0
- 30,000 shares@ US$1.01Common StockSEC:0001161697-08-000008:1
- 44,200 shares@ US$1.00Common StockSEC:0001161697-07-001228:0
- 50,000 shares@ US$0.55Common StockSEC:0001161697-07-001228:1
- 657,690 sharesCommon StockSEC:0001161697-07-000876:0
- 680,000 shares@ US$0.55Common StockSEC:0001161697-07-000876:1
8 of 8 declarations
About Lotus Pharmaceuticals, Inc.
Lotus Pharmaceuticals, Inc. is a company focused on the development and commercialization of pharmaceutical products. It is listed on NASDAQ under the ticker XNAS.
